Jazz Pharmaceuticals PLC (HAM:J7Z)
€ 209.5 +9.8 (+4.91%) Market Cap: 13.30 Bil Enterprise Value: 15.53 Bil PE Ratio: 0 PB Ratio: 3.45 GF Score: 73/100

Jazz Pharmaceuticals PLC at Jefferies Global Healthcare Conference in New York Transcript

Jun 03, 2026 / 02:30PM GMT
Release Date Price: €194.5 (-2.38%)
Akash Tewari
Jefferies LLC - Analyst

Hello everyone. I really appreciate it. I hope the morning is extremely well. My name is Akash Tewari. I'm a pharma and biotech analyst here at Jefferies.

This is day one of at least the public portion of our New York City Healthcare Conference. Very pleased to have Jazz Pharmaceuticals, one of our high conviction bets in biotech and a company that I think is really at a point where they're seeing a transition to becoming really a full-fledged biotech story scaling and I think something that investors should be paying attention to.

Rob, why don't I hand it off to you to give some introductory remarks, and then we'll get started with Q&A.

Unidentified Company Representative;Robert Iannone
Jazz Pharmaceuticals PLC -

Thanks, Akash, for having us. And just a quick comment that Rob and I will be making some forward-looking statements today. So please do refer to our risk factors in our SEC documents and any guidance we refer to as our first quarter guidance that we provided.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot